Cargando…
Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivo
AIMS: Aspirin has been used for the secondary prevention and treatment of cardiovascular disease for several decades. We investigated the roles of transcriptional factor activator protein 2α (AP-2α) in the beneficial effects of aspirin in the growth and vulnerability of atherosclerotic plaque. METHO...
Autores principales: | Yang, Jing-Jing, Li, Peng, Wang, Fu, Liang, Wen-Jing, Ma, Hui, Chen, Yuan, Ma, Zhi-Min, Li, Quan-Zhong, Peng, Qi-Sheng, Zhang, Yun, Wang, Shuang-Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288144/ https://www.ncbi.nlm.nih.gov/pubmed/27391154 http://dx.doi.org/10.18632/oncotarget.10400 |
Ejemplares similares
-
Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms
por: Ma, Hui, et al.
Publicado: (2017) -
Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque
por: Pan, Chang, et al.
Publicado: (2016) -
The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020) -
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020) -
Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability
por: Zhao, Huiying, et al.
Publicado: (2017)